Theravance Biopharma, Inc. (TBPH)

18.25 +0.06 (+0.33%) USD  |  NASDAQ  |  Feb 27, 16:00
18.26 +0.01 (+0.05%) After-Hours: 20:00
More

Theravance Biopharma Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Integer Holdings Corp. Upgrade
QuidelOrtho Corp. Upgrade
Corcept Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Innoviva, Inc. Upgrade